Differential toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics

Clinical and Vaccine Immunology

Volumn 18, Issue 4, 2011, Pages 621-628

  Plantinga, Theo S ^a   Van Maren, Wendy W C ^a   Van Bergenhenegouwen, Jeroen ^b   Hameetman, Marjolijn ^a   Nierkens, Stefan ^a   Jacobs, Cor ^a   De Jong, Dirk J ^a   Joosten, Leo A B ^a   Van't Land, Belinda ^b,c   Garssen, Johan ^b,c   Adema, Gosse J ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LECTIN RECEPTOR; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE;

ANIMALS; BIFIDOBACTERIUM; CELLS, CULTURED; CYTOKINES; HUMANS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MICE; MICE, INBRED C57BL; PROBIOTICS; TOLL-LIKE RECEPTORS;

EID: 79954562343     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00498-10     Document Type: Article

References (48)

1. Agrawal, S., et al. 2003. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J. Immunol. 171:4984-4989. (Pubitemid 37432777)
2. Barton, G. M., and J. C. Kagan. 2009. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat. Rev. Immunol. 9:535-542.
3. Bauer, S., et al. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 98:9237-9242.
4. Boge, T., et al. 2009. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27:5677-5684.
5. Borruel, N., et al. 2003. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am. J. Gastroenterol. 98:865-870.
6. + T cells via modulation of dendritic cell function. Am. J. Clin. Nutr. 80:1618-1625.
7. Carol, M., et al. 2006. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease. J. Leukoc. Biol. 79:917-922.
8. Christensen, H. R., H. Frokiaer, and J. J. Pestka. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:171-178.
9. Dillon, S., et al. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172:4733-4743. (Pubitemid 38456394)
10. Foligne, B., et al. 2007. A key role of dendritic cells in probiotic functionality. PLoS. One 2:e313.
11. Gorbach, S. L. 2000. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 95:S2-S4.
12. Haller, D., et al. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J. Nutr. 140:690S-697S.
13. Helwig, U., et al. 2006. Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J. Gastroenterol. 12:5978-5986.
14. Hemmi, H., et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745. (Pubitemid 32015992)
15. Hoarau, C., C. Lagaraine, L. Martin, F. Velge-Roussel, and Y. Lebranchu. 2006. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 117:696-702.
16. Imaoka, A., et al. 2008. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J. Gastroenterol. 14:2511-2516.
17. Kaji, R., J. Kiyoshima-Shibata, M. Nagaoka, M. Nanno, and K. Shida. 2010. Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J. Immunol. 184:3505-3513.
18. Kawase, M., F. He, A. Kubota, G. Harata, and M. Hiramatsu. 2010. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Lett. Appl. Microbiol. 51:6-10.
19. Llopis, M., et al. 2009. Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa. Inflamm. Bowel. Dis. 15:275-283.
20. Lorea, B. M., P. V. Kirjavainen, S. Hekmat, and G. Reid. 2007. Antiinflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 149:470-479.
21. Lutz, M. B., et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92. (Pubitemid 29096240)
22. Lutz, M. B., et al. 2000. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30:1813-1822.
23. + T regulatory cells is protective in murine allergy models. Clin. Exp. Allergy 40:811-819.
24. Matsuoka, K., et al. 2004. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 53:1303-1308. (Pubitemid 39120117)
25. Medina, M., E. Izquierdo, S. Ennahar, and Y. Sanz. 2007. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin. Exp. Immunol. 150:531-538.
26. Miyazato, A., et al. 2009. Toll-like receptor 9-dependent activation of myeloid dendritic cells by deoxynucleic acids from Candida albicans. Infect. Immun. 77:3056-3064.
27. Netea, M. G., et al. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172:3712-3718. (Pubitemid 38337955)
28. Netea, M. G., J. W. van der Meer, R. P. Sutmuller, G. J. Adema, and B. J. Kullberg. 2005. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob. Agents Chemother. 49:3991-3996.
29. Neurath, M. F., et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:1129-1143.
30. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353-364.
31. Popa, C., et al. 2007. Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4. Infect. Immun. 75:4831-4837.
32. + T cells. Immunity 1:553-562.
33. Rabot, S., J. Rafter, G. T. Rijkers, B. Watzl, and J. M. Antoine. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism. J. Nutr. 140:677S-689S.
34. Ramirez-Ortiz, Z. G., et al. 2008. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect. Immun. 76:2123-2129.
35. Re, F., and J. L. Strominger. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276:37692-37699.
36. Redecke, V., et al. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172:2739-2743. (Pubitemid 38263655)
37. Rovedatti, L., et al. 2009. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 58:1629-1636.
38. Schultz, M., et al. 2003. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J. Dairy Res. 70:165-173. (Pubitemid 36599405)
39. Seiderer, J., et al. 2008. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm. Bowel. Dis. 14:437-445.
40. Shida, K., J. Kiyoshima-Shibata, M. Nagaoka, K. Watanabe, and M. Nanno. 2006. Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion. J. Dairy Sci. 89:3306-3317. (Pubitemid 44305973)
41. Sutmuller, R. P., et al. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116:485-494.
42. Takeuchi, O., et al. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451. (Pubitemid 29504199)
43. Vidal, M., et al. 2010. Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J. Clin. Microbiol. 48:2595-2598.
44. Wada, M., et al. 2010. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support. Care Cancer 18:751-759.
45. Wang, H. B., et al. 2001. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis. J. Immunol. 166:6430-6436.
46. Weiss, G., et al. 2010. Bifidobacterium bifidum actively changes the gene expression profile induced by Lactobacillus acidophilus in murine dendritic cells. PLoS. One 5:e11065.
47. Wolvers, D., et al. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J. Nutr. 140:698S-712S.
48. Zeuthen, L. H., L. N. Fink, and H. Frokiaer. 2008. Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology 124:489-502. (Pubitemid 351962545)